Ms. Cantagallo is a highly accomplished Senior Executive with more than 30 years of success in the healthcare and life sciences industries. Leveraging in-depth experience to the Vice President level in all phases of product/drug development (startup, Phase I-phase IV and Life Cycle Management) , including successful development, approval and commercialization of late stage small molecule pharmaceuticals (CRESTOR ® and Movantik ®).
Some highlighted areas of expertise include: Grant Writing, Proof of Concept planning, business strategy, partner evaluations, Go/No Go decision analysis, clinical and regulatory processes from IND through NDA.
Kathleen received her BS in Chemical Engineering, MS in Industrial Management from Widener University, and has strategic leadership certifications from both MIT and Harvard.
